PureFlora Inc. Welcomes Christopher Jones as Chief Technology Officer to Better Serve the Microbiome Research and Clinical Communities

Share Article

Appointment of new Chief Technology Officer to accelerate the development of the company's technology for the collection, processing, and delivery of human gut microbiota.

News Image
Interest and investment in the human gut microbiome has soared in the last few years but credible research and clinical applications demand process standardization

PureFlora today announced the addition of Christopher Jones to its executive team in the role of Chief Technology Officer. An early advisor and contributor to the development of the PureFlora technology, Jones’ re-engagement catalyzes the completion of a refined prototype of the company’s device for the collection, processing, and delivery of fecal matter containing microbiota for clinical and research applications.

A seasoned medical device executive, Jones led R&D teams at VNUS Medical Technologies and VidaMed whose flagship product portfolios were key to successful IPOs and subsequent high value acquisitions by Covidien and Medtronic, respectively. Following a product development role at Stryker Endoscopy and tenure as Vice-President, R&D at Magenta Medical, Jones became President of AirXpanders, leading the company through development and international clinical trials before focusing on his most recent industry role as an angel investor, strategic advisor, and mentor.

“Interest and investment in the human gut microbiome has soared in the last few years but credible research and clinical applications demand process standardization," said Amanda Cooper, CEO at PureFlora, “We are committed to meeting that urgent need in a timely manner and Chris Jones' proven expertise in developing successful medical device technology swiftly and efficiently will be instrumental in achieving that.”

A named inventor of 40 U.S. patents related to medical technologies, Jones earned a B.S. degree in Mechanical Engineering from Stanford University and an M.S. degree in Engineering from the Massachusetts Institute of Technology.

About PureFlora

PureFlora was founded in 2012 by Tivon Sidorsky, MD after a family member’s severe case of C. difficile introduced him to the efficacy of fecal matter transplants (FMT) and the need for a standardized, sanitary, and labor reducing system by which to collect, process, and deliver fecal matter. Recognizing the tremendous opportunity for research and clinical applications for human gut microbiota and the elegant solution proposed by Dr. Sidorsky, veteran medical device executive William L. Mince joined forces with the inventor building the now-patented technology and team that is PureFlora.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Amanda Cooper
+1 650-731-3011 Ext: 700
Email >
PureFlora Inc.
since: 10/2016
Like >
PureFlora Inc.

Visit website